[go: up one dir, main page]

NO984602D0 - Procedure for the detection of prion-mediated diseases - Google Patents

Procedure for the detection of prion-mediated diseases

Info

Publication number
NO984602D0
NO984602D0 NO984602A NO984602A NO984602D0 NO 984602 D0 NO984602 D0 NO 984602D0 NO 984602 A NO984602 A NO 984602A NO 984602 A NO984602 A NO 984602A NO 984602 D0 NO984602 D0 NO 984602D0
Authority
NO
Norway
Prior art keywords
prion
procedure
detection
mediated diseases
mediated
Prior art date
Application number
NO984602A
Other languages
Norwegian (no)
Other versions
NO321571B1 (en
NO984602L (en
Inventor
Bram Edward Cornelis Schreuder
Lucius Johannes Mattheu Keulen
Maria Elisabeth Wilhel Vromans
Johannes Pieter Mari Langeveld
Marinus Adrianus Smits
Original Assignee
Stichting Inst Dierhouderij
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223847&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984602(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Inst Dierhouderij filed Critical Stichting Inst Dierhouderij
Publication of NO984602D0 publication Critical patent/NO984602D0/en
Publication of NO984602L publication Critical patent/NO984602L/en
Publication of NO321571B1 publication Critical patent/NO321571B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19984602A 1996-04-03 1998-10-01 Procedure for immunological screening of prion disease, diagnostic test kit for such screening, and use of the test kit. NO321571B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200917 1996-04-03
PCT/NL1997/000166 WO1997037227A1 (en) 1996-04-03 1997-04-02 Method for the detection of prion diseases

Publications (3)

Publication Number Publication Date
NO984602D0 true NO984602D0 (en) 1998-10-01
NO984602L NO984602L (en) 1998-12-03
NO321571B1 NO321571B1 (en) 2006-06-06

Family

ID=8223847

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984602A NO321571B1 (en) 1996-04-03 1998-10-01 Procedure for immunological screening of prion disease, diagnostic test kit for such screening, and use of the test kit.

Country Status (13)

Country Link
US (2) US6972177B1 (en)
EP (1) EP0891552B2 (en)
JP (1) JP3333213B2 (en)
AR (1) AR006494A1 (en)
AT (1) ATE236407T1 (en)
AU (1) AU713529B2 (en)
BR (1) BR9708421A (en)
CA (1) CA2250800C (en)
DE (1) DE69720433T3 (en)
DK (1) DK0891552T4 (en)
NO (1) NO321571B1 (en)
NZ (1) NZ332132A (en)
WO (1) WO1997037227A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2319607A (en) * 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
NZ333518A (en) * 1997-02-06 2001-06-29 Enfer Technology Ltd Immunological assay for spongiform encephalopathies (TSE)
US6165784A (en) * 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
DE19804216C2 (en) * 1998-02-03 1999-12-16 Schebo Tech Gmbh Method for the detection of central nervous tissue in products, in particular meat products, and a test kit therefor
CA2364686C (en) 1999-02-11 2007-04-24 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prion test
US6605445B1 (en) 1999-02-22 2003-08-12 Bayer Corporation Rapid method of determining clearance of prion protein
DE19918141A1 (en) * 1999-04-21 2000-10-26 Boehringer Ingelheim Vetmed Diagnosing transmissible spongiform encephalopathy, particularly before appearance of clinical symptoms, by detecting specific markers in blood cells
WO2001019867A1 (en) * 1999-09-14 2001-03-22 Memorec Stoffel Gmbh Prion-related protein
FR2806802B1 (en) * 2000-03-24 2002-06-21 Eurofins Scient METHOD AND INSTALLATION FOR CONFIRMING THE ABSENCE IN INFECTIOUS PRION PROTEINS
DE10108099A1 (en) * 2001-02-19 2002-09-12 Cenas Ag Method for detection of specific proteins and use
EP1382971A1 (en) * 2002-07-17 2004-01-21 Pepscan Systems B.V. Detection of prion disease
US20060184001A1 (en) * 2005-02-02 2006-08-17 Minkoff Lawrence A Method for MRI scanning of animals for transmissible spongiform encephalopathies
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
EP2403871A4 (en) * 2009-03-02 2013-01-16 Univ British Columbia SPECIFIC ANTIBODIES AND EPITOPES OF A PRION PROTEIN
JP5861256B2 (en) * 2011-01-25 2016-02-16 富士通株式会社 Agricultural work support method and agricultural work support apparatus
WO2020231913A1 (en) * 2019-05-10 2020-11-19 New York University Compositions and methods for the treatment and prevention of prion disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806627A (en) 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
AU4376093A (en) * 1992-05-15 1993-12-13 Instituto Nazionale Neurologico C. Besta Soluble prion polypeptides, and methods for detecting and purifying thereof
JP3495738B2 (en) * 1995-09-14 2004-02-09 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア Natural PrPsc-specific antibody
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
US6150172A (en) 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein

Also Published As

Publication number Publication date
DK0891552T4 (en) 2009-05-04
BR9708421A (en) 1999-08-03
EP0891552B1 (en) 2003-04-02
AU2180897A (en) 1997-10-22
AU713529B2 (en) 1999-12-02
US20050048582A1 (en) 2005-03-03
US7211401B2 (en) 2007-05-01
WO1997037227A1 (en) 1997-10-09
CA2250800C (en) 2004-02-17
ATE236407T1 (en) 2003-04-15
CA2250800A1 (en) 1997-10-09
EP0891552A1 (en) 1999-01-20
NZ332132A (en) 2000-02-28
US6972177B1 (en) 2005-12-06
DK0891552T3 (en) 2003-07-21
DE69720433D1 (en) 2003-05-08
DE69720433T3 (en) 2009-07-30
JP3333213B2 (en) 2002-10-15
EP0891552B2 (en) 2008-12-31
JP2000505559A (en) 2000-05-09
AR006494A1 (en) 1999-08-25
NO321571B1 (en) 2006-06-06
DE69720433T2 (en) 2004-03-11
NO984602L (en) 1998-12-03

Similar Documents

Publication Publication Date Title
NO976063D0 (en) Procedure for the treatment of diabetes
NO984602D0 (en) Procedure for the detection of prion-mediated diseases
NO991382L (en) Intermediates and process for the preparation of olanzapine
NO974316D0 (en) Process for the preparation of beveled catheters
NO20000189L (en) Process for the preparation of heparin
AU5811498A (en) Microsphere-enhanced immunoassay for the detection of veterinary diseases
NO964084D0 (en) Detection of analytes
NO996432D0 (en) Process for the preparation of 4-substituted-1H-indole-3-glycosamides
NO304110B1 (en) Process for the preparation of glutardialdehyde
NO991158D0 (en) Procedure for the treatment of amyotrophic lateral sclerosis
NO982503D0 (en) Process for the preparation of dioxoazabicyclohexanes
NO994749D0 (en) Process for the preparation of tetraazamacrocycles
NO980316D0 (en) Process for the preparation of N-vinylcarprolactam polymerisates
NO20001793L (en) Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
NO994557D0 (en) Process for the preparation of arylaminotriazolopyridines
NO930436L (en) Procedure for the preparation of bathrooms
NO953459D0 (en) Process for the preparation of cycloheptimidazole derivatives
NO972813L (en) Procedure for monitoring the integrity of position determination
NO20002476L (en) Process for the preparation of formylimidazoles
BR9704770A (en) Derivatives of 1-carba- (detia) -cephalosporin
NO20002267D0 (en) Procedure for the preparation of citalopram
NO20002077L (en) Procedure for the preparation of citalopram
FI964721A0 (en) Maneuvering of the bastion
KR970004363U (en) Centrifuge for the treatment of contaminants
BR9605659A (en) Set of goggles

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees